Skip to content
Clinical Trials – home

Generalised anxiety disorder Diagnostics

2 / 4 trials open to patients10 countries

In short

Diagnosing generalised anxiety disorder involves more than a single test—it requires careful evaluation of symptoms, medical history, and sometimes physical exams to rule out other conditions that might be causing similar feelings of worry and stress.

Key points

  • Diagnosing generalised anxiety disorder relies on clinical evaluation, patient history, and standardised questionnaires—not on blood tests or brain scans.
  • The GAD-7 is a simple, validated tool that helps doctors measure the severity of anxiety symptoms and track progress over time.
  • Physical exams and laboratory tests are often used to rule out other medical conditions that can mimic anxiety symptoms, such as thyroid disorders or heart problems.
  • Only 43% of people with generalised anxiety disorder receive treatment, even though effective therapies are available.
  • People with anxiety disorders are twice as likely to present with unexplained physical symptoms, which can delay proper diagnosis.
  • Clinical trials use more rigorous diagnostic procedures, including structured interviews and strict inclusion criteria, to ensure accurate results.
  • Generalised anxiety disorder often occurs alongside other mental health conditions like depression, so a comprehensive evaluation is important.
  • Early diagnosis and treatment can significantly improve quality of life and reduce the risk of complications like social isolation or substance use.

Introduction: Who Should Undergo Diagnostics and When to Seek Help

It is completely normal to feel anxious from time to time, especially when facing stressful situations like work deadlines, financial concerns, or family problems. However, when worry becomes so frequent and intense that it interferes with your daily activities, relationships, or ability to function at work or school, it may be time to seek professional help.

You should consider seeing a healthcare provider if you notice that your worries are difficult to control and occur most days over a period of at least six months. This is particularly important if the anxiety causes you significant distress or makes it hard to carry out everyday tasks. People with generalised anxiety disorder—a condition where excessive worry affects multiple areas of life—often experience both emotional symptoms like persistent fear and physical symptoms like fatigue, muscle tension, or trouble sleeping.

Many people with generalised anxiety disorder delay seeking help because they may not recognise their symptoms as a medical condition, or they might feel embarrassed about their feelings. However, early diagnosis is important because it opens the door to effective treatments that can significantly improve quality of life. If you often feel overwhelmed, find it difficult to relax, or notice physical symptoms like headaches or stomach problems without a clear medical cause, it is advisable to talk to a doctor.

It is especially important to seek help if anxiety symptoms are accompanied by other mental health concerns such as depression, mood swings, or thoughts of self-harm. Generalised anxiety disorder can raise the risk of suicidal thoughts, so reaching out for professional support is crucial if you ever feel this way.

In some cases, people may first consult their primary care doctor about physical symptoms like fatigue or difficulty sleeping, only to discover that anxiety is the underlying cause. This is common, as patients with anxiety disorders are more likely to have chronic medical problems and may not initially connect their physical discomfort with their emotional state.

Diagnostic Methods: How Generalised Anxiety Disorder Is Identified

Diagnosing generalised anxiety disorder is not as straightforward as performing a single blood test or scan. Instead, it relies on a combination of clinical evaluation, patient history, questionnaires, and sometimes physical examinations or laboratory tests to rule out other conditions that might mimic anxiety symptoms.

Clinical Evaluation and Medical History

When you visit a healthcare provider with concerns about anxiety, they will begin by asking detailed questions about your symptoms and medical history. This conversation is essential because it helps the doctor understand the nature, frequency, and severity of your worries, as well as how they affect your daily life. You may be asked about when your symptoms started, what situations trigger your anxiety, and whether you have a family history of mental health conditions.

The doctor will also want to know about any physical symptoms you experience, such as muscle tension, restlessness, difficulty concentrating, or trouble sleeping. It is important to be as honest as possible during this conversation, even if talking about your emotions feels difficult. This openness helps the doctor make an accurate diagnosis and recommend the most appropriate treatment.

Diagnostic Criteria from the DSM-5

Healthcare providers use standardised criteria to diagnose generalised anxiety disorder. The most widely used set of criteria comes from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published by the American Psychiatric Association. According to the DSM-5, a diagnosis of generalised anxiety disorder requires the following:

  • Excessive anxiety and worry occurring more days than not for at least six months, about a number of events or activities such as work, school, or health
  • Difficulty controlling the worry
  • The presence of three or more symptoms (only one in children), such as restlessness, being easily fatigued, difficulty concentrating, irritability, muscle tension, or sleep disturbance
  • The anxiety, worry, or physical symptoms cause significant distress or impairment in social, occupational, or other important areas of functioning
  • The symptoms are not due to the effects of a substance (such as a medication or drug) or another medical condition (such as an overactive thyroid)
  • The symptoms are not better explained by another mental disorder, such as panic disorder or social anxiety disorder

This structured approach ensures that the diagnosis is based on clear, consistent criteria and helps distinguish generalised anxiety disorder from other conditions with overlapping symptoms.

Screening Tools and Questionnaires

To help assess the severity of anxiety symptoms and support the diagnostic process, healthcare providers often use validated screening tools. One of the most commonly used questionnaires is the GAD-7 (Generalised Anxiety Disorder 7-item scale). This short, simple questionnaire asks patients to rate how often they have been bothered by seven different anxiety-related symptoms over the past two weeks.

The GAD-7 is not used to make a definitive diagnosis on its own, but it provides a standardised way to measure the severity of anxiety and track changes over time. Scores can help doctors understand whether symptoms are mild, moderate, or severe, and whether treatment is working.

Other psychological questionnaires may also be used to assess related conditions, such as depression, since generalised anxiety disorder often occurs alongside other mental health disorders.

Physical Examination and Laboratory Tests

Because anxiety symptoms can sometimes be caused or worsened by underlying medical conditions, your doctor may perform a physical examination and order blood or urine tests. These tests help rule out other health problems that can cause similar symptoms, such as an overactive thyroid (hyperthyroidism), heart conditions, or hormonal imbalances.

For example, certain medications or substances like caffeine, alcohol, or recreational drugs can also trigger or worsen anxiety symptoms. Your doctor will ask about your use of these substances to determine whether they might be contributing to your condition.

If a medical condition is suspected, additional tests may be ordered. However, in most cases, generalised anxiety disorder is diagnosed based on symptoms and clinical evaluation rather than laboratory findings.

Distinguishing Generalised Anxiety Disorder from Other Conditions

One of the challenges in diagnosing generalised anxiety disorder is that its symptoms overlap with other anxiety disorders and mental health conditions. For instance, people with panic disorder experience sudden, intense episodes of fear known as panic attacks, while those with phobias have overwhelming fear related to specific objects or situations.

Generalised anxiety disorder is different because the worry is not limited to one specific trigger—it spans many different areas of life and persists over a long period. The healthcare provider will carefully review your symptoms to determine whether they fit the pattern of generalised anxiety disorder or another condition.

It is also common for people with generalised anxiety disorder to experience symptoms of depression at the same time. In such cases, both conditions need to be addressed in the treatment plan.

Referral to Mental Health Specialists

In many cases, a primary care doctor will refer patients to a mental health specialist, such as a psychologist or psychiatrist, for further evaluation and treatment. Mental health professionals have specialised training in diagnosing and treating anxiety disorders and can provide more in-depth assessments.

If you are referred to a specialist, they may conduct additional interviews, use more detailed questionnaires, or explore the history of your symptoms in greater depth. This comprehensive approach ensures that the diagnosis is accurate and that the treatment plan is tailored to your specific needs.

Diagnostics for Clinical Trial Qualification

When patients are being considered for participation in clinical trials for generalised anxiety disorder, more rigorous and standardised diagnostic procedures are typically used. Clinical trials are research studies designed to test the safety and effectiveness of new treatments, and they require precise criteria to ensure that all participants truly have the condition being studied.

Structured Diagnostic Interviews

Clinical trials often use structured diagnostic interviews conducted by trained professionals. These interviews follow a specific format and cover all the criteria outlined in the DSM-5 or other diagnostic manuals. The goal is to ensure that every participant meets the exact definition of generalised anxiety disorder and to exclude those whose symptoms might be better explained by another condition.

These interviews are more detailed than a typical doctor's visit and may take longer to complete. They help researchers create a homogeneous study population, which makes it easier to determine whether a treatment is effective.

Severity Assessment and Symptom Duration

Clinical trials usually have specific inclusion criteria related to the severity and duration of symptoms. For example, a trial might only accept participants who have had symptoms for at least six months and whose GAD-7 scores fall within a certain range, indicating moderate to severe anxiety. These criteria ensure that the treatment is tested in patients who are most likely to benefit from it.

Researchers may also use additional questionnaires or scales to measure anxiety levels, functional impairment, and quality of life. These tools provide baseline data that can be compared to results after treatment, helping scientists understand how well the intervention works.

Exclusion of Other Medical and Psychiatric Conditions

To ensure the safety and validity of the study, clinical trials typically require thorough screening for other medical and psychiatric conditions. This may include physical examinations, blood tests, and assessments for substance use disorders or other mental health conditions that could interfere with the study.

For instance, if a participant has an untreated thyroid disorder that is contributing to their anxiety symptoms, they might be excluded from the trial until that condition is addressed. Similarly, individuals with severe depression or substance use disorders may need to be treated for those conditions separately.

Prognosis and Survival Rate

Prognosis

The outlook for people with generalised anxiety disorder varies, but with appropriate treatment, many individuals can experience significant improvement in their symptoms and quality of life. Generalised anxiety disorder is often a long-term condition, meaning it may persist for years or even a lifetime. However, it can be managed effectively with the right combination of therapies, medications, and self-care strategies.

The condition usually begins in childhood or adolescence, with peak onset in late adolescence or early adulthood, though it can also develop later in life. The course of the disorder is often chronic, with symptoms that may come and go, and tend to worsen during periods of high stress. Factors that can affect prognosis include the severity of symptoms, the presence of other mental health conditions like depression or substance use disorders, and whether the person receives timely and appropriate treatment.

People who receive effective treatment, such as cognitive behavioural therapy or medications like selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), often see significant improvement in their symptoms. However, relapses can occur, particularly if treatment is stopped prematurely. For this reason, many healthcare providers recommend continuing treatment for at least six to twelve months after symptoms improve to reduce the risk of relapse.

Around half of patients treated for generalised anxiety disorder may fail to respond to initial treatment, a situation referred to as treatment-resistant or refractory generalised anxiety disorder. In such cases, additional strategies such as augmentation with other medications or adjustments to therapy may be needed.

Survival rate

Generalised anxiety disorder is not a life-threatening condition in the way that diseases like cancer or heart disease are, so the concept of a "survival rate" does not directly apply. However, it is important to understand that untreated or poorly managed anxiety can have serious consequences for overall health and wellbeing. People with generalised anxiety disorder are at increased risk of developing other mental health conditions, such as depression and substance use disorders, and they may also experience complications like social isolation, difficulties at work or school, and impaired relationships.

There is also an increased risk of suicidal thoughts and behaviours in people with generalised anxiety disorder, particularly when it occurs alongside depression or other mental health problems. This underscores the importance of seeking help and receiving appropriate treatment. With proper care, most people with generalised anxiety disorder can lead fulfilling lives and manage their symptoms effectively, improving their long-term health outcomes and quality of life.

Did you know?

  1. Generalised anxiety disorder affects about 3% of the adult U.S. population currently and 5% of people at any point during their lives, yet only 43% of those affected are receiving treatment[2].
  2. People with anxiety disorders are twice as likely to present with physical symptoms like muscle aches or stomach problems that have no clear medical cause, which can lead to repeated doctor visits before the anxiety is properly diagnosed[4].
  3. The GAD-7 questionnaire, which is widely used to screen for generalised anxiety disorder, consists of just seven simple questions about how often a person has been bothered by anxiety symptoms over the past two weeks[4].

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Generalised anxiety disorder

Recruiting trials first

See all 4 trials →
Quick filters

4 clinical trials in this condition

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Iti-1284
  • Sponsor:Intra-Cellular Therapies Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Iti-1284
  • Sponsor:Intra-Cellular Therapies Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LYSERGIDE
  • Sponsor:Definium Therapeutics US Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ulotaront
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.
See all 4 trials →filters applied: condition = Generalised anxiety disorder

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).